<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Buserelin: endometriosis; Buserelin: in vitro fertilisation; Suprecur; Buserelin: endometriosis" /><meta name="IX" content="Suprecur; Buserelin: endometriosis" /><meta name="IXM" content="Buserelin: endometriosis; Buserelin: in vitro fertilisation" /><title>BUSERELIN: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="4469.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="4469.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=4469.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2073.htm">6 Endocrine system</a> &gt; <a href="4457.htm">6.7 Other endocrine drugs</a> &gt; <a href="4462.htm">6.7.2 Drugs affecting gonadotrophins</a> &gt; <a href="4468.htm">Gonadorelin analogues</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="4468.htm" title="Previous: Gonadorelin analogues">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4470.htm#_4470" title="Next: Suprecur®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (4)</h3></li><li><a href="4470.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Suprecur®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.7 Other endocrine drugs &gt; 6.7.2 Drugs affecting gonadotrophins &gt; Gonadorelin analogues &gt; BUSERELIN</p></div></li><li><a href="21856.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.3 Sex hormones and hormone antagonists in malignant disease &gt; 8.3.4 Hormone antagonists</p></div></li><li><a href="4824.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">BUSERELIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.3 Sex hormones and hormone antagonists in malignant disease &gt; 8.3.4 Hormone antagonists &gt; 8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists &gt; Gonadorelin analogues</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22buserelin%22%22buserelin%22%22buserelin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0250.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buserelin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; B</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/b08-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buserelin</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; B</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-11280-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buserelin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Sex Hormones and their Modulators &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01503.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Buserelin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; B &gt; BU</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_4469">BUSERELIN</h1><?highlighter on?><div id="pC" class="jN"><div class="cAF"><h2>Indications</h2> <p class="cAF">see under Dose; prostate
cancer (<a title=" Prostate cancer and gonadorelin analogues" href="21856.htm#_21856">section 8.3.4.2</a>)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="target-block: Gonadorelin analogue cautions" href="4468.htm#_4468.1">notes above</a>; polycystic ovarian disease, depression, hypertension, diabetes</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">see <a title="target-block: Gonadorelin analogue contra-indications" href="4468.htm#_4468.2">notes above</a>; hormone-dependent tumours</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:monograph-family: Gonadorelin analogues" href="4468.htm#_4468">notes above</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">see <a title="BNF:monograph-family: Gonadorelin analogues" href="4468.htm#_4468">notes above</a></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see notes above; initially withdrawal bleeding
and subsequently breakthrough bleeding, leucorrhoea; nausea, vomiting,
constipation, diarrhoea; anxiety, memory and concentration disturbances,
sleep disturbances, nervousness, dizziness, drowsiness; breast tenderness,
lactation; abdominal pain; fatigue; increased thirst, changes in appetite;
acne, dry skin, splitting nails, dry eyes; altered blood lipids, leucopenia,
thrombocytopenia; hearing disturbances; reduced <span>glucose</span> tolerance</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Endometriosis, <span class="cU">intranasally</span>, 300 micrograms
(one 150-microgram spray in each nostril) 3 times daily (starting
on days 1 or 2 of menstruation); max. duration of treatment 6 months
(do not repeat)</p><p class="cR">Pituitary desensitisation before induction of ovulation
by gonadotrophins for <i>in vitro</i> fertilisation (under
specialist supervision), <span class="cU">by subcutaneous injection</span>,
200–500 micrograms daily given as a single injection (occasionally
up to 500 micrograms twice daily may be needed) starting in early
follicular phase (day 1) <i>or</i>, after exclusion of pregnancy,
in midluteal phase (day 21) and continued until down-regulation achieved
(usually about 1–3 weeks) then maintained during gonadotrophin administration
(stopping gonadotrophin and <span>buserelin</span> on administration
of <span>chorionic gonadotrophin</span> at appropriate stage
of follicular development)</p><p class="cS"><span class="cU">Intranasally</span>, 150 micrograms (one spray in one
nostril) 4 times daily during waking hours (occasionally up to 300 micrograms
4 times daily may be needed) starting in early follicular phase (day
1) <i>or</i>, after exclusion of pregnancy, in midluteal
phase (day 21) and continued until down-regulation achieved (usually
about 2–3 weeks) then maintained during gonadotrophin administration
(stopping gonadotrophin and <span>buserelin</span> on administration
of <span>chorionic gonadotrophin</span> at appropriate stage
of follicular development)</p><div class="cAT"><h3>Counselling</h3> <p class="cAX">Avoid use of nasal decongestants before
and for at least 30 minutes after treatment</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="4470.htm#_4470" title="Suprecur®">Suprecur®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="4468.htm">Previous: Gonadorelin analogues</a> | <a class="top" href="4469.htm#">Top</a> | <a accesskey="]" href="4470.htm#_4470" title="Suprecur®">Next: Suprecur®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>